(Q48742900)

English

A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study).

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22286203

A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study). (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22286203

1 reference

based on heuristic

inferred from title

Michael J Pencina

5

object named as

Michael Pencina

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22286203

author name string

Maurizio Fava

1

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22286203

David Mischoulon

2

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22286203

Dan Iosifescu

3

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22286203

Janet Witte

4

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22286203

Martina Flynn

6

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22286203

Linda Harper

7

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22286203

Michael Levy

8

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22286203

Karl Rickels

9

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22286203

Mark Pollack

10

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22286203

publication date

25 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22286203

Psychotherapy and Psychosomatics

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22286203

81

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22286203

2

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22286203

87-97

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22286203

Diagnosis and definition of treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1159%2F000332050

21 January 2018

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

1 reference

https://api.crossref.org/works/10.1159%2F000332050

21 January 2018

Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials

1 reference

https://api.crossref.org/works/10.1159%2F000332050

21 January 2018

The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1159%2F000332050

21 January 2018

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1159%2F000332050

21 January 2018

The Problem of the Placebo Response in Clinical Trials for Psychiatric Disorders: Culprits, Possible Remedies, and a Novel Study Design Approach

1 reference

https://api.crossref.org/works/10.1159%2F000332050

21 January 2018

The PHQ-9: validity of a brief depression severity measure

1 reference

https://api.crossref.org/works/10.1159%2F000332050

21 January 2018

Redefining affective disorders: relevance for drug development

1 reference

https://api.crossref.org/works/10.1159%2F000332050

21 January 2018

The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a

1 reference

https://api.crossref.org/works/10.1159%2F000332050

21 January 2018

RESEARCH: Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ).

1 reference

https://api.crossref.org/works/10.1159%2F000332050

21 January 2018

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1159%2F000332050

21 January 2018

An open trial of oral sildenafilin antidepressant-induced sexual dysfunction

1 reference

https://api.crossref.org/works/10.1159%2F000332050

21 January 2018

An examination of the efficiency of the sequential parallel design in psychiatric clinical trials.

1 reference

https://api.crossref.org/works/10.1159%2F000332050

21 January 2018

Fifty years with the Hamilton scales for anxiety and depression. A tribute to Max Hamilton

1 reference

https://api.crossref.org/works/10.1159%2F000332050

21 January 2018

The mechanisms of tolerance in antidepressant action

1 reference

https://api.crossref.org/works/10.1159%2F000332050

21 January 2018

Atypical antipsychotics: CATIE study, drug-induced movement disorder and resulting iatrogenic psychiatric-like symptoms, supersensitivity rebound psychosis and withdrawal discontinuation syndromes.

1 reference

https://api.crossref.org/works/10.1159%2F000332050

21 January 2018

Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission

1 reference

https://api.crossref.org/works/10.1159%2F000332050

21 January 2018

Struggle for subtypes in primary and secondary depression and their mode-specific treatment or healing.

1 reference

https://api.crossref.org/works/10.1159%2F000332050

21 January 2018

Subtyping major depressive disorder

1 reference

https://api.crossref.org/works/10.1159%2F000332050

21 January 2018

The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression

1 reference

https://api.crossref.org/works/10.1159%2F000332050

21 January 2018

Identifiers

10.1159/000332050

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22286203

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22286203

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48742900&oldid=1413210384"